Association between simulated ketamine exposures and oxygen saturations in children.
Abstract
<h4>Aim</h4>We performed a real-world data analysis to evaluate the relationship between
simulated ketamine exposures and oxygen desaturation in children.<h4>Materials & methods</h4>A
previously developed population pharmacokinetic model was used to simulate exposures
and evaluate target attainment, as well as the association with oxygen desaturation
in children ≤17 years treated with intravenous ketamine.<h4>Results</h4>In 2022 children,
there was no significant association between simulated plasma ketamine concentrations
and oxygen saturation; however, a higher cumulative area under the curve was associated
with increased odds of progression to significant desaturation (<85%), though magnitude
of effect was small.<h4>Conclusion</h4>By leveraging a population pharmacokinetic
model and real-world data, we confirmed there is no relationship between simulated
ketamine plasma concentration and oxygen desaturation.
Type
Journal articleSubject
ketamineoxygen desaturation
real-world data
respiratory compromise
simulated plasma concentration
Permalink
https://hdl.handle.net/10161/27381Published Version (Please cite this version)
10.4155/ipk-2022-0003Publication Info
Commander, Sarah Jane; Gonzalez, Daniel; Kumar, Karan R; Spears, Tracy; Cohen-Wolkowiez,
Michael; Zimmerman, Kanecia O; ... Hornik, Christoph P (2023). Association between simulated ketamine exposures and oxygen saturations in children.
International journal of pharmacokinetics, 6(1). pp. IPK03. 10.4155/ipk-2022-0003. Retrieved from https://hdl.handle.net/10161/27381.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Michael Cohen-Wolkowiez
Kiser-Arena Distinguished Professor
Pediatric and adult clinical pharmacology and clinical trials.
Sarah Jane Commander
House Staff
Daniel Gonzalez
Instructor in the Department of Medicine
Dr. Daniel Gonzalez is a clinical pharmacologist in the Division of Clinical Pharmacology
of the Department of Medicine at the Duke University School of Medicine, and a member
of the Duke Clinical Research Institute. Gonzalez received his PharmD and PhD from
the University of Florida College of Pharmacy in 2008 and 2012, respectively. He then
completed a postdoctoral fellowship through the UNC-Duke Collaborative Clinical Pharmacology
T32 Postdoctoral Training Program. Following completion of his
Christoph Paul Vincent Hornik
Professor of Pediatrics
Karan Ravindra Kumar
Assistant Professor of Pediatrics
Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info